Safety and efficacy of conversion from once daily Sandimmune to twice daily Neoral cyclosporine in renal allograft recipients
10.1016/S0041-1345(98)00413-8
Saved in:
Main Authors: | Vathsala, A, Lee, WT, Lu, YM, Woo, KT |
---|---|
Other Authors: | MEDICINE |
Format: | Conference or Workshop Item |
Published: |
ELSEVIER SCIENCE INC
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/229704 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Conversion from once-daily Sandimmune cyclosporine to once-daily Neoral in renal transplant patients
by: Arvind, C, et al.
Published: (2022) -
Conversion from Sandimmune to Neoral in renal allograft recipients
by: Vathsala, A
Published: (2022) -
Conversion from twice-daily prograf to once-daily advagraf in multi-ethnic asian adult renal transplant recipients with or without concomitant use of diltiazem - impact of CYP3A5 genetic polymorphism on tacrolimus pharmacokinetics
by: Yau, Wai-Ping, et al.
Published: (2022) -
Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression
by: Lou, HX, et al.
Published: (2022) -
Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study
by: Sayamon Sukkha, et al.
Published: (2018)